Hosseini Seyed Hamzeh, Ezzati Ghadi Fereshteh, Ramzani Ghara Abdollah, Cerulli Antonietta, Shakeri Abolfazl, Piacente Sonia
Department of Biology, Faculty of Science, University of Jiroft, Jiroft, Iran.
Dipartimento di Farmacia, Università degli Studi di Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Salerno, Italy.
Iran J Basic Med Sci. 2022 Dec;25(12):1433-1441. doi: 10.22038/IJBMS.2022.65646.14441.
In this study, to find scientific evidence for the traditional use of as an anti-diabetic remedy, the effects of its aqueous extract on streptozotocin-induced diabetes mellitus in rats were evaluated.
Wistar rats were fasted overnight and diabetes mellitus was induced using streptozotocin (50 mg/kg body weight). The rats were randomly and equally divided into four groups (n=5): group I (normoglycaemic control), group II (diabetic rats), group III (diabetic rats treated with 200 mg/kg BW of an aqueous extract of ), group IV (normoglycemic rats treated with 200 mg/kg BW of an aqueous extract of ). Chemical profiling of the aqueous extract was carried out using liquid chromatography coupled with electrospray ionization and multiple-stage linear ion-trap and orbitrap high-resolution mass spectrometry (LC-ESI/LTQOrbitrap/MS/MS). In addition, the quantitative determination of the main cardenolides in the extract was carried out by an analytical approach based on LC coupled to tandem mass spectrometry with ESI source and hybrid triple quadrupole-linear ion trap mass analyzer (LC-ESI/QTrap/MS/MS).
Aqueous extract of showed a reasonable reduction in blood glucose level. Probably, the effect on hyperglycemic and hyperlipidemic diabetic animals was associated with antioxidant properties, triglyceride levels, as well as liver enzymes. Meanwhile, LC-ESI/LTQOrbitrap/MS/MS analysis led to identification of double-linked cardenolides along with cardenolides and flavone glycosides as the main bioactive compounds.
The extract decreased the glucose level and induced a beneficial effect on the lipid profile, probably due to the presence of cardenolide glycosides.
在本研究中,为 将其作为抗糖尿病药物的传统用途寻找科学依据,评估了其水提取物对链脲佐菌素诱导的大鼠糖尿病的影响。
Wistar大鼠禁食过夜,使用链脲佐菌素(50mg/kg体重)诱导糖尿病。大鼠被随机且等分为四组(n = 5):第一组(血糖正常对照组),第二组(糖尿病大鼠组),第三组(用200mg/kg体重的 水提取物治疗的糖尿病大鼠组),第四组(用200mg/kg体重的 水提取物治疗的血糖正常大鼠组)。使用液相色谱与电喷雾电离以及多级线性离子阱和轨道阱高分辨率质谱联用(LC - ESI/LTQOrbitrap/MS/MS)对水提取物进行化学分析。此外,通过基于液相色谱与串联质谱联用(配有电喷雾电离源和混合三重四极杆 - 线性离子阱质谱分析仪,LC - ESI/QTrap/MS/MS)的分析方法对提取物中的主要强心苷进行定量测定。
的水提取物显示出血糖水平有合理降低。可能, 对高血糖和高血脂糖尿病动物的作用与抗氧化特性、甘油三酯水平以及肝酶有关。同时,LC - ESI/LTQOrbitrap/MS/MS分析导致鉴定出双链强心苷以及强心苷和黄酮糖苷作为主要生物活性化合物。
该提取物降低了血糖水平,并对脂质谱产生有益影响,可能是由于存在强心苷糖苷。